A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518833-27-00

Acronym

QRL-101-06

Enrollment

Registered

2024-12-19

Start date

2025-01-10

Completion date

2025-05-15

Last updated

2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis (ALS)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026